1-15 of 622
Rethinking Who Qualifies for Advanced IBD Therapy
GI InsightsRethinking Who Qualifies for Advanced IBD Therapy
Aligning Medical and Patient Goals in IBD Treatment
GI InsightsAligning Medical and Patient Goals in IBD Treatment
ADHD Is Linked to a Broad Burden of GI Symptoms
NeuroFrontiersADHD Is Linked to a Broad Burden of GI Symptoms
Microbiome Signature May Help Predict Infliximab Response in Crohn’s Disease
GI InsightsMicrobiome Signature May Help Predict Infliximab Response in Crohn’s Disease
Diet-Microbiome Links Diverge in Crohn’s Disease and Ulcerative Colitis
GI InsightsDiet-Microbiome Links Diverge in Crohn’s Disease and Ulcerative Colitis
Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Clinician's RoundtableClosing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
- advertisement
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Clinician's RoundtableClosing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Gastric Cancer Prevention: A Risk-Based Approach
GI InsightsGastric Cancer Prevention: A Risk-Based Approach
Improving Long-Term Adherence to CRC Screening Recommendations
Clinician's RoundtableImproving Long-Term Adherence to CRC Screening Recommendations
Rising Colorectal Cancer in Young Adults: Implications for Screening
Clinician's RoundtableRising Colorectal Cancer in Young Adults: Implications for Screening
Navigating Classification of High-Grade Neuroendocrine Neoplasms
Project Oncology®Navigating Classification of High-Grade Neuroendocrine Neoplasms
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Project Oncology®Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
- advertisement
Managing Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
GI InsightsManaging Early Esophageal and Gastric Cancers: ASGE Recommendations on ESD and EMR
Screening Modalities for Colon Cancer: What You Need to Know
GI InsightsScreening Modalities for Colon Cancer: What You Need to Know
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Project Oncology®Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data



























































